EG427 Press Releases - EIN Presswire - Press Release Distribution Service

Published on February 13, 2024 - 07:00 GMT

EG 427 Announces Attendance at Conferences in H1 2024

PARIS, FRANCE, February 13, 2024 /⁨EINPresswire.com⁩/ -- EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions based on its unique non-replicative HSV-1 vector platform, announces today it will present at several …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 14, 2023 - 06:30 GMT

EG 427 Appoints Don Haut, Ph.D as Chief Business Officer and Opens US Headquarters

Brings 20+ years of senior leadership roles and deal making experience, including in gene therapy. New Boston office supports the growth of global BD strategy. PARIS, FRANCE, December 14, 2023 /⁨EINPresswire.com⁩/ -- EG 427, a biotechnology company …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on November 7, 2023 - 20:25 GMT

EG427 Announces Positive Preclinical Results from EG110A IND-Enabling Study in Neurogenic Bladder and Overactive Bladder

The data represents a pivotal milestone and paves the way for an Investigational New Drug (IND) application. PARIS, FRANCE, November 7, 2023 /⁨EINPresswire.com⁩/ -- EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...